← Leaderboards
Tara Butler
Leidos Biomedical Research, Inc.
$264,992
Attributed
$264,992
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $189.3K · FY2020–22$200K$150K$100K$50K$0
'20
'21
'22
Funding mix
By agency
NIH$264,992 · 1
By mechanism
N01$264,992 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- David Lindsay$51,337,878
- Christopher Case$10,132,080
- Matt Westerman$8,377,026
- Gautam Mitra$3,186,514
Others in their field
Other Emerging Leaders on “Vaccines”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$149,372,007
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Ted Ross · University Of Georgia$71,962,304
Research focus
VaccinesAntibodiesAnticancer ResearchAntigensBaseBiological ProductsCgmp ProductionCyclic GmpDna VaccinesEngineeringGp160Hiv Envelope Protein Gp120Hiv VaccineImmunogenicityLaboratoriesMemoryMolecular ConformationMonocytePhase I Clinical TrialsProgram DevelopmentProteinsResponseSafetyVaccine Candidate
Grant awards (3)
CGMP MANUFACTURE OF TWO HIV DNA VACCINES AND ONE HIV PROTEIN VACCINE COMPONENT$57,745
N01 · FY2022 · CA · contact PI
CGMP MANUFACTURE OF TWO HIV DNA VACCINES AND ONE HIV PROTEIN VACCINE COMPONENT$189,261
N01 · FY2021 · CA · contact PI
CGMP MANUFACTURE OF TWO HIV DNA VACCINES AND ONE HIV PROTEIN VACCINE COMPONENT$17,986
N01 · FY2020 · CA · contact PI